This article is free to access.
The article reports that pharmaceutical firm AbbVie has withdrawn its legal opposition to the European Medicines Agency's (EMA) plan to release clinical trial data for its drug Humira to the public as of June 2014.
Sinha, G. (2014). AbbVie drops transparency fight. Nature Biotechnology, 32(6), 507–507. https://doi.org/10.1038/nbt0614-507b